Factors associated with acute-phase response of bisphosphonate-naïve or pretreated women with osteoporosis receiving an intravenous first dose of zoledronate or ibandronate
Crossref DOI link: https://doi.org/10.1007/s00198-017-3992-5
Published Online: 2017-03-15
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Popp, A.W.
Senn, R.
Curkovic, I.
Senn, C.
Buffat, H.
Popp, P.F.
Lippuner, K. http://orcid.org/0000-0002-7195-3779
License valid from 2017-03-15